Hyperphosphatemia

• FDA approval · 2008-02-26
  FDA Approved: CALCIUM ACETATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA Inc.'s calcium acetate for use as a phosphate binder in patients with hyperphosphatemia due to chroni…

• FDA approval · 2007-10-19
  FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)

  FDA approved SEVELAMER CARBONATE (Sanofi-Aventis U.S. LLC) for control of serum phosphate in adults with chronic kidney disease on dialysis.

• FDA approval · 2007-08-14
  FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approved a supplemental application for Sevelamer hydrochloride (Renagel) filed by Sanofi-Aventis U.S. LLC.